cdmo.directory
← Compare landing

HAS Healthcare Advanced Synthesis SA vs 重庆兴泰濠制药有限公司 (Sintaho)

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/hashealthcare/sintaho

CategoryHAS Healthcare Advanced Synthesis SA重庆兴泰濠制药有限公司 (Sintaho)
Listed sitecdmocdmo
SummaryHAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.
Services
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Small Molecule Development & Manufacturing
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Small Molecule
  • Peptide
Indications
  • Oncology
Data not yet provided.
Locations
  • Biasca, Biasca, Switzerland
  • Headquarters, Chongqing, Chongqing, China
CertificationsData not yet provided.
  • Internet Drug Information Service Qualification (Chongqing) · Identifier: （渝）-非经营性-2022-0020
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.